11.26
前日終値:
$12.16
開ける:
$12.17
24時間の取引高:
335.88K
Relative Volume:
0.97
時価総額:
$378.27M
収益:
-
当期純損益:
$-47.20M
株価収益率:
-7.1935
EPS:
-1.5653
ネットキャッシュフロー:
$-43.65M
1週間 パフォーマンス:
-10.21%
1か月 パフォーマンス:
-13.65%
6か月 パフォーマンス:
+16.68%
1年 パフォーマンス:
+0.00%
Mbx Biosciences Inc Stock (MBX) Company Profile
MBX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MBX
Mbx Biosciences Inc
|
11.26 | 408.50M | 0 | -47.20M | -43.65M | -1.5653 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-05 | 開始されました | Mizuho | Outperform |
2025-07-16 | 開始されました | Oppenheimer | Outperform |
2025-04-10 | 開始されました | Citizens JMP | Mkt Outperform |
2024-10-08 | 開始されました | Guggenheim | Buy |
2024-10-08 | 開始されました | JP Morgan | Overweight |
2024-10-08 | 開始されました | Jefferies | Buy |
2024-10-08 | 開始されました | Stifel | Buy |
すべてを表示
Mbx Biosciences Inc (MBX) 最新ニュース
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recoverySummary of Trade Cycles in 5-Year Range - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsReal Time Screener for Growth Trades - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Free ROI Driven Equity Selection With Safety - Newser
What’s next for MBX Biosciences Inc. stock priceFree Low Volatility Stable Growth Picks - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
MBX Biosciences Inc. recovery potential after sell offHigh Yield Watchlist with Filtered Picks - Newser
MBX Biosciences Inc. Forms Bullish Flag — Upside AheadBreakout Entry Signal Confirmation Tool Used - beatles.ru
MBX Biosciences (NYSE:MBX) Research Coverage Started at Mizuho - Defense World
Mbx Biosciences (MBX) Q2 Loss Widens 22% - Nasdaq
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
MBX Biosciences Reveals Triple Clinical Trial Progress, Secures 2-Year Cash Runway With $224M - Stock Titan
Volatility clustering patterns for MBX Biosciences Inc.Free Chart Breakout Buy Signal Detection - Newser
How MBX Biosciences Inc. stock performs during market volatilitySmart Entry Signals for Active Traders - Newser
Mizuho Securities Initiates MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $38 - 富途牛牛
Analyst Upgrades and Initiations for Tuesday: Lionsgate Studios, MBX Biosciences, D-Wave Quantum, APA Corporation, and Quince Therapeutics - AInvest
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Mizuho Initiates MBX Biosciences at Outperform - MarketScreener
Mizuho initiates MBX Biosciences stock with Outperform rating on promising pipeline - Investing.com Nigeria
MBX Biosciences initiated with an Outperform at Mizuho - TipRanks
RSI Crosses Above 30 for MBX Biosciences Inc. — Reversal in SightSector Rotation Based Trading Opportunities Identified - metal.it
What is MBX Biosciences Inc. company’s growth strategyCapitalize on fast-moving stock trends - Jammu Links News
What is the dividend policy of MBX Biosciences Inc. stockInvest smarter with advanced market data - Jammu Links News
When is MBX Biosciences Inc. stock expected to show significant growthFree High-Return Strategy Alerts - Jammu Links News
What are the latest earnings results for MBX Biosciences Inc.Get exclusive access to professional stock picks - Jammu Links News
Why is MBX Biosciences Inc. stock attracting strong analyst attentionDiscover hidden gems in the stock market - Jammu Links News
How does MBX Biosciences Inc. compare to its industry peersTremendous wealth creation - Jammu Links News
What makes MBX Biosciences Inc. stock price move sharplyUnlock powerful stock screening tools - Jammu Links News
Is MBX Biosciences Inc. a good long term investmentUnprecedented profit potential - Jammu Links News
What are MBX Biosciences Inc. company’s key revenue driversGet expert insights on market-moving stocks - Jammu Links News
What institutional investors are buying MBX Biosciences Inc. stockAdvanced Screener Data Feed To Watch Now - Jammu Links News
Is It Too Early to Call Recovery in MBX Biosciences Inc.AI Based High Gain Watchlist Scanner Shared - metal.it
Mbx Biosciences Inc (MBX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):